Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Hubert Fleury, Nicolas Malaquin, Véronique Tu, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

Exploiting senescence for the treatment of cancer
Liqin Wang, Lina Lankhorst, René Bernards
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 340-355
Open Access | Times Cited: 521
Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 451
The metabolic roots of senescence: mechanisms and opportunities for intervention
Christopher D. Wiley, Judith Campisi
Nature Metabolism (2021) Vol. 3, Iss. 10, pp. 1290-1301
Open Access | Times Cited: 421
Senescent Cells in Cancer Therapy: Friends or Foes?
Boshi Wang, Jaskaren Kohli, Marco Demaria
Trends in cancer (2020) Vol. 6, Iss. 10, pp. 838-857
Open Access | Times Cited: 388
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Mariana Paes Dias, Sarah C. Moser, Shridar Ganesan, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 773-791
Closed Access | Times Cited: 359
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
Pataje G.S. Prasanna, Deborah E. Citrin, Jeffrey Hildesheim, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 10, pp. 1285-1298
Open Access | Times Cited: 243
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Tareq Saleh, Sarah Bloukh, Valerie J. Carpenter, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 822-822
Open Access | Times Cited: 227
A Senescence-Centric View of Aging: Implications for Longevity and Disease
Michela Borghesan, Willem M.H. Hoogaars, Marta Varela-Eirín, et al.
Trends in Cell Biology (2020) Vol. 30, Iss. 10, pp. 777-791
Open Access | Times Cited: 205
Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies
Lynda Wyld, Ilaria Bellantuono, Tamar Tchkonia, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2134-2134
Open Access | Times Cited: 190
DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy
Jiayu Zhang, Cheng Yang, Chunfu Wu, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2123-2123
Open Access | Times Cited: 172
The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy
Alakananda Basu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107943-107943
Closed Access | Times Cited: 125
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
Loretah Chibaya, Jarin T. Snyder, Marcus Ruscetti
Seminars in Cancer Biology (2022) Vol. 86, pp. 827-845
Open Access | Times Cited: 84
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications
Saiyang Xie, Si‐Chi Xu, Wei Deng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 77
Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
Rana Salam, Alexa Saliou, Franck Bielle, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 76
Guidelines for minimal information on cellular senescence experimentation in vivo
Mikołaj Ogrodnik, Juan Carlos Acosta, Peter D. Adams, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4150-4175
Open Access | Times Cited: 67
The senescence journey in cancer immunoediting
Alessandra Zingoni, Fabrizio Antonangeli, Silvano Sozzani, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Win Topatana, Sarun Juengpanich, Shijie Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 134
Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction
Tareq Saleh, Valerie J. Carpenter, Liliya Tyutyunyk‐Massey, et al.
Molecular Oncology (2020) Vol. 14, Iss. 10, pp. 2504-2519
Open Access | Times Cited: 131
Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
Simona D’Aguanno, Donatella Del Bufalo
Cells (2020) Vol. 9, Iss. 5, pp. 1287-1287
Open Access | Times Cited: 124
Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
Guo Hua, Chunfang Ha, Hui Dong, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 98
Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer
Cecilia R. Chambers, Shona Ritchie, Brooke A. Pereira, et al.
Molecular Oncology (2021) Vol. 15, Iss. 12, pp. 3242-3255
Open Access | Times Cited: 96
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Valerie J. Carpenter, Tareq Saleh, David A. Gewirtz
Cancers (2021) Vol. 13, Iss. 4, pp. 723-723
Open Access | Times Cited: 90
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation
Mara Bonelli, Silvia La Monica, Claudia Fumarola, et al.
Biochemical Pharmacology (2019) Vol. 170, pp. 113676-113676
Closed Access | Times Cited: 86
Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls
W. Andrew Owens, Anna Walaszczyk, Ioakim Spyridopoulos, et al.
Mechanisms of Ageing and Development (2021) Vol. 198, pp. 111540-111540
Open Access | Times Cited: 82
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Francisco Triana-Martínez, Marı́a Isabel Loza, Eduardo Domínguez
Cells (2020) Vol. 9, Iss. 2, pp. 346-346
Open Access | Times Cited: 81
Page 1 - Next Page

Scroll to top